{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:37:40Z","timestamp":1725496660113},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,4]]},"DOI":"10.7759\/cureus.68628","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T11:51:58Z","timestamp":1725450718000},"source":"Crossref","is-referenced-by-count":0,"title":["A Presentation of Neisseria meningitidis in a Patient Taking Adalimumab as Immunosuppressive Therapy for Hidradenitis Suppurativa"],"prefix":"10.7759","author":[{"given":"Jacob  W","family":"Bolling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron D","family":"Holley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleon","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-346-2_1","article-title":"Neisseria meningitidis: biology, microbiology, and epidemiology.","volume":"799","author":"Rouphael NG","year":"2012","unstructured":"Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology.. Methods Mol Biol. 2012, 799:1-20. 10.1007\/978-1-61779-346-2_1","journal-title":"Methods Mol Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20090513","article-title":"Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease","volume":"118","author":"Hill DJ","year":"2010","unstructured":"Hill DJ, Griffiths NJ, Borodina E, Virji M. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci (Lond). 2010, 118:547-564. 10.1042\/CS20090513","journal-title":"Clin Sci (Lond)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012393","article-title":"Pathogenesis of meningococcemia","volume":"3","author":"Coureuil M","year":"2013","unstructured":"Coureuil M, Join-Lambert O, L\u00e9cuyer H, Bourdoulous S, Marullo S, Nassif X. Pathogenesis of meningococcemia. Cold Spring Harb Perspect Med. 2013, 3:10.1101\/cshperspect.a012393","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref4","unstructured":"Risk Factors for Meningococcal Disease | Meningococcal | CDC. (2024). Accessed. March 10, 2024: https:\/\/www.cdc.gov\/meningococcal\/about\/risk-factors.html."},{"key":"ref5","unstructured":"Meningococcal Disease - DynaMed. (2023). Accessed. March 10, 2024: https:\/\/www.dynamed.com\/condition\/meningococcal-disease."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12570","article-title":"Bacterial meningitis in solid organ transplant recipients: a population-based prospective study","volume":"18","author":"van Veen KE","year":"2016","unstructured":"van Veen KE, Brouwer MC, van der Ende A, van de Beek D. Bacterial meningitis in solid organ transplant recipients: a population-based prospective study. Transpl Infect Dis. 2016, 18:674-680. 10.1111\/tid.12570","journal-title":"Transpl Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-016-9705-6","article-title":"Bacterial meningitis in patients using immunosuppressive medication: a population-based prospective nationwide study","volume":"12","author":"van Veen KE","year":"2017","unstructured":"van Veen KE, Brouwer MC, van der Ende A, van de Beek D. Bacterial meningitis in patients using immunosuppressive medication: a population-based prospective nationwide study. J Neuroimmune Pharmacol. 2017, 12:213-218. 10.1007\/s11481-016-9705-6","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref8","unstructured":"SOLIRIS\u00ae (eculizumab) HCP | MOA. (2024). Accessed. March 10, 2024: https:\/\/solirisnmosd-hcp.com\/about-soliris\/mechanism-of-action."},{"key":"ref9","unstructured":"ULTOMIRIS\u00ae (ravulizumab-cwvz) | PNH home. (2024). Accessed. March 10, 2024: https:\/\/ultomirishcp.com\/pnh?gclid=CjwKCAiAibeuBhAAEiwAiXBoJEBKLT_c2JEAvolaUu4GVC0OeWCSYqhsbYOACnuWT1z4W2vNmLWLcRoCOl...."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2019.08.014","article-title":"Subacute meningococcaemia during adalimumab therapy","volume":"146","author":"Salinas N","year":"2019","unstructured":"Salinas N, Etienne M, Roguedas AM, Le Flahec G, Misery L. Subacute meningococcaemia during adalimumab therapy. Ann Dermatol Venereol. 2019, 146:817-820. 10.1016\/j.annder.2019.08.014","journal-title":"Ann Dermatol Venereol"},{"key":"ref11","article-title":"Drug focus: adalimumab in the treatment of moderate to severe psoriasis","volume":"1","author":"Vena GA","year":"2007","unstructured":"Vena GA, Cassano N. Drug focus: adalimumab in the treatment of moderate to severe psoriasis. Biologics. 2007, 1:93-103.","journal-title":"Biologics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF alpha and the TNF receptor superfamily: structure-function relationship(s)","volume":"50","author":"Idriss HT","year":"2000","unstructured":"Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech. 2000, 50:184-195. 10.1002\/1097-0029(20000801)50:3&lt;184::AID-JEMT2&gt;3.0.CO;2-H","journal-title":"Microsc Res Tech"},{"key":"ref13","unstructured":"HUMIRA\u00ae (adalimumab) Commitment to Clinical Evidence. (2024). Accessed. March 10, 2024: https:\/\/www.humirapro.com\/about-humira."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/239663-a-presentation-of-neisseria-meningitidis-in-a-patient-taking-adalimumab-as-immunosuppressive-therapy-for-hidradenitis-suppurativa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T11:52:05Z","timestamp":1725450725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/239663-a-presentation-of-neisseria-meningitidis-in-a-patient-taking-adalimumab-as-immunosuppressive-therapy-for-hidradenitis-suppurativa"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.68628","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,4]]}}}